education
|
points
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
Hong Kong
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Others Services
Download App
Hong Kong
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
education
|
points
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
MIMS home
Drugs
Info
Berirab P
Berirab P
rabies immunoglobulin
Manufacturer:
CSL Behring
Distributor:
Primal
SELECT
Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Adverse Reactions
Drug Interactions
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Adverse Reactions
Drug Interactions
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Contents
Human rabies Ig
Indications/Uses
Post-exposure prophylaxis of rabies infection, to be administered exclusively in conjunction w/ a rabies vaccination.
Click to view Berirab P detailed prescribing information
Dosage/Direction for Use
20 IU/kg body wt IM, administered as deeply as possible into & around the wound. Inj the remainder into the vastus lateralis muscle w/ the patient lying down.
Click to view Berirab P detailed prescribing information
Contraindications
Intravascular inj.
Click to view Berirab P detailed prescribing information
Special Precautions
Observe patient for 20 min after administration. Pregnancy & lactation.
Click to view Berirab P detailed prescribing information
Use In Pregnancy & Lactation
Click to view Berirab P detailed prescribing information
Adverse Reactions
Local reaction at inj site. Rarely, hypotension, dyspnoea, cutaneous reactions, anaphylactic shock, chills, fever, headache, malaise, nausea, vomiting, arthralgia & moderate back pain, CV reactions.
Click to view Berirab P detailed prescribing information
Drug Interactions
Allow 3 mth interval prior to vaccination of live virus vaccines. False positive result in serological testing.
Click to view Berirab P detailed prescribing information
Storage
View
Berirab P storage
conditions for details to ensure optimal shelf-life.
Description
View
Berirab P description
for details of the chemical structure and excipients (inactive components).
Action
View
Berirab P mechanism of action
for pharmacodynamics and pharmacokinetics details.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J06BB05 - rabies immunoglobulin ; Belongs to the class of specific immunoglobulins. Used in passive immunizations.
Regulatory Classification
P
1
S
1
S
3
Presentation/Packing
Form
Berirab P vaccine (pre-filled syringe) 300 IU/2 mL
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Continue with Google
OR
Sign Up
Already a member?
Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Continue with Google
OR
Sign Up
Already a member?
Sign in